Patented Products 
 Oncology Formulations
  Therapeutic
    
Segments

 Anaesthetics

 Anthelmintic

 Anti Hypertensives

 Anti- Ulcler Agents

 Anti-Asthamatic

 Anti-Diabetic

 Anti-Fungal

 Anti-Histamines

 Anti-Microbials

 Anti-Tussives

 Drugs In Osteoporosis

 Haematinic And Nutritional Supplement

 NSAIDs

 Skeletal Muscle Relaxants

 Oncology API
 Specialty APIs
 Chiral intermediates
Anti-Diabetic
Gliclaz Each uncoated tablet contains:Gliclazide B.P. 80 mg
Gliclaz - m Gliclazide 80mg + Metformin 500mg
Glimchek 1mg Each tablet contains:Glimepiride 1mg
Glimchek -m1 Each uncoated bilayered tablet contains:Glimepiride 1mg Metformin Hydrochloride I.P. 500mg ( in sustained release form)
Logit 15 Each film coated tablet contains:Pioglitazone 15mg
P&m Pioglitazone 15mg + Metformin (ER) 500mg
Roftem-sr 500 Each film coated tablet contains:Metformin SR 500mg
Glimchek 2mg Each tablet contains:Glimepiride 2mg
Glimchek -m2 Each uncoated bilayered tablet contains:Glimepiride 2mg Metformin Hydrochloride I.P. 500mg ( in sustained release form)
Roftem-sr 1000 Each film coated tablet contains:Metformin SR 1000mg
Logit 30 Each film coated tablet contains:Pioglitazone 30mg
 

Present

Introduced Patented Products based on NDDS
(Marketed in India and out-Licensed for the Developing Countries)

  

Future

Patents driven by NDDS, Nano and Dendrimers
(To be marketed in India and to be out Licensed to the developed countries)

 
   
© 2001 - 2007 Khandelwal Laboratories Pvt. Ltd. All rights reserved.